Gold Sponsors

Cadence

MedTorque

Millstone Medical

Phillips


Supporting Organizations

Bartlett Chamber of Commerce

EDGE

GMMDC

Greater Memphis Chamber


Media Sponsors

Media

Silver Sponsors

Arch Medical Solutions

EPTAM Precision Solutions

Gauthier Biomedical

Lavezzi

MedBio

NTK

Steri-Tek

Structure Medical

Tegra Medical


Bronze Sponsors

Micro Mold

Orchid

Plastikos

Lisa Ferrara

Lisa Ferrara, Ph.D., Owner and President, OrthoKinetic Technologies/OrthoKinetic Testing Technologies
Lisa Ferrara, Ph.D. is currently the owner and president of OrthoKinetic Technologies, a medical device regulatory consulting firm and OrthoKinetic Testing Technologies, an A2LA accredited and IEC/ISO 17025 certified medical device test facility that provide a turn-key approach for medical device evaluation and regulatory success. Academically, she held a joint appointment for the Departments of Neurosurgery and Orthopedic Surgery at The Cleveland Clinic Foundation, where she founded the Spine Research Laboratory and served as the director from 1999 until 2003. During her 25 years of academic research, she has authored more than 50 technical publications, 25 book chapters, has been granted multiple patents, and given over 60 invited presentations on novel technologies, biomaterials, nanotechnology and nanomedicine, musculoskeletal and spinal biomechanics, biomechanics of brain injury, additive manufacturing, and regulatory strategies. She also serves on multiple healthcare advisory boards, the Southeastern Regional Biotechnology Advisory Board for North Carolina, editorial staff of multiple orthopedic and spine medical journals, and was highlighted in the National Association of Distinguished Professionals as one of the top 100 industry experts in medical devices.

Chuck Hansford

Chuck Hansford, Director of Advanced Materials Processing, Tecomet Inc.
Chuck Hansford, director of advanced materials processing with Tecomet Inc., oversees all additive manufacturing, R&D, and production at multiple Tecomet sites. He joined the company in 2017 with 35 years of product development experience and 26 years of additive manufacturing experience (plastic and metal). Previously, he was a senior manager of prototype development with Ethicon Endo-Surgery (J&J), before moving on to Morris Technologies as VP of medical, responsible for all subtractive and additive manufacturing business. While at Morris, Hansford’s team was responsible for the development of the first two 510(k)-cleared additive manufactured implants from DMLS technology, which are still in production. He is published in several trade magazines and has multiple patents on endoscopic medical devices. He holds multiple Bachelor degrees from the University of Cincinnati.

Bryan Hughes

Bryan Hughes, Director, P&M Corporate Finance
Bryan Hughes is a director of PMCF and leads the firm’s medical technology team. His practice focuses on assisting medical technology and medical manufacturing clients with mergers and acquisitions, leveraged buyouts, private placements, financings, valuation and strategic consulting. His clients have ranged from global medical technology companies to small, privately held businesses.

Dean Hughes

Dean Hughes, M.S., P.E., VP Knee Product Development, Smith and Nephew
Dean Hughes, M.S., P.E., joined Smith and Nephew Orthopaedics in 1993, where he currently serves as VP Knee Product Development. Over the last 25 years, he has obtained 27 U.S. Patents within knee, shoulder, and spine arthroplasty. Hughes has led and been responsible for over 50 project launches within the GII, Legion, and Journey product families. He holds a BSME and MS in Mechanical Engineering from University of Memphis, as well as, an MBA from Christian Brothers University. Hughes is a Registered Professional Engineer in the state of Tennessee and has held multiple positions at Smith and Nephew within engineering and manufacturing.

David Kelman

David C. Kelman, President, Kelman & Company Consulting LLC
David C. Kelman, president of Kelman & Company Consulting LLC, is a licensed professional engineer who has managed and led design and development teams on three different continents for major orthopedic companies. He is a creative innovator whose broad scope of solutions has resulted in two unique start-up businesses, commercialization of 40 product platforms, and 50 U.S. patents awarded. As a multifaceted problem solver, he incorporates technological and business sophistication across diverse environments, including product design/software/analytics/supply chain/technical marketing and sales. This unique mix of technical, engineering, and business expertise has resulted in successful business strategies, and the introduction of cutting-edge technologies with financial viability.

Dawn Lissy

Dawn A. Lissy, President & Founder, Empirical
Dawn Lissy is a biomedical engineer, entrepreneur, and innovator. Since 1998, the Empirical family of companies (Empirical Testing Corp., Empirical Consulting, LLC, and Empirical Machine, LLC) has operated under Lissy’s direction. Empirical offers the full range of regulatory and quality systems consulting, testing, small batch and prototype manufacturing, and validations services to bring a medical device to market. Empirical is very active within standards development organization ASTM International and has one of the widest scopes of test methods of any accredited independent lab in the United States. Because Lissy was a member of the U.S. Food and Drug Administration’s Entrepreneur-in-Residence program, she has first-hand, in-depth knowledge of the regulatory landscape. Lissy holds an inventor patent for the Stackable Cage System for corpectomy and vertebrectomy. Her M.S. in biomedical engineering is from The University of Akron, Ohio.

Brian McLaughlin

Brian R. McLaughlin, Founder & CEO, Amplify Inc.
Most recently, Brian McLaughlin was VP of Engineering, Quality, and Operations for an early stage orthopedic company focused on leveraging additive manufacturing (AM) for unique foot and ankle implants. The company—originally McLaughlin’s vision—had achieved five FDA clearances for 3D printed titanium implants. He left the company last July to pursue his current startup, Amplify Inc., a contract design and manufacturing organization focused on helping orthopedic OEMs leverage AM for their unique implant solutions. Prior to this, McLaughlin was the additive manufacturing business unit manager for DTI, an Arcam company, which was acquired by GE Additive and is now Oerlikon AM. DTI was a contract manufacturer for orthopedic implants and McLaughlin’s team was focused on leveraging EBM for the design and manufacturing of 3D printed titanium implants for OEM clients. He managed six Arcam Q10 EBM machines supporting over 40 clients. McLaughlin also worked for Orchid Orthopaedic Solutions, the second largest CMO in the U.S. for orthopedics. In addition to engineering and manufacturing experience, he has experience as an orthopedic sales representative, selling extremity implants and gaining valuable clinical experience in the OR working with clinicians and administration. McLaughlin also has extensive design experience across various other industries and has been using 3D printing his entire career.

Bryce Rutter

Bryce G. Rutter Ph.D., Founder and CEO, Metaphase Design Group Inc.
Dr. Bryce Rutter, founder and CEO of Metaphase Design Group Inc., is a leading expert in the research, ergonomics, and design of medical products and a worldwide specialist in hand-intensive products and packaging. His work includes collaborations with numerous global prestigious brands and high-profile start-ups on products ranging from robotic surgical systems, powered and manual instrument design, and drug delivery systems to disposables, mobile and wearable devices, to personal care products, IFUs, and usability and contextual inquiry research programs. Metaphase delivers innovative designs that redefine industry standards, invigorate sleepy brands, and create new product categories. Under Dr. Rutter’s leadership, Metaphase has received more than 120 international design excellence awards and 117 patents. Dr. Rutter holds degrees in industrial design and a Ph.D. in kinesiology, specializing in hand function.

Dan Sands

Dan Sands, CEO, Director, AMB Surgical
Dan Sands has 27 years of experience exclusively in the orthopedic and healthcare supply chain markets. He has held various leadership positions in product development, sales, marketing, and manufacturing throughout his career. Sands has developed and commercialized over 20 medical products, RFID, and software platforms; holds multiple patents; and has raised millions in capital to support the six start-ups he’s either founded or led over the years. In his spare time, Sands is an advisory board member and adjunct professor, teaching the next generation of entrepreneur’s for Ball State University’s Miller College of Business nationally ranked entrepreneurship program.

Christine Scifert

Christine Scifert, Co-Founder, MRC-X LLC
Christine Scifert is co-founder of MRC-X LLC (previously Memphis Regulatory Consulting LLC), which offers services in the regulatory, quality, reimbursement, compliance, and clinical areas related to medical devices. She has been consulting for 10 years and has assisted both small and large medical device companies with strategy, regulatory submissions, quality systems, training, due diligence, and many other activities. Prior to consulting, Scifert spent 9 years at Medtronic Spinal and Biologics, directing the regulatory department of 22 people. Prior to Medtronic, she performed evaluations of injury mechanisms associated with automobile collisions, slip and falls, and sport/recreation accidents. Scifert received a Bachelor’s of Science in Physics from Hamline University and a Master’s of Science in Biomedical Engineering from University of Iowa. She also completed a Master’s in Engineering Management from Christian Brothers University.

Scott Shankle

Scott Shankle, Vice-President of Operations, MicroPort Orthopedics Inc.
Scott Shankle has been part of the MicroPort Orthopedics Inc. team since the inception of the company in January 2014 and is currently the vice president of Operations. Prior to the acquisition of Wright Medical Technology’s OrthoRecon Business by MicroPort, Shankle held various roles of increasing responsibility within Quality and Operations at Wright for 15 years. This experience cumulated with the role of senior director of global quality, which he held from 2011 through the acquisition in 2014. Shankle holds Bachelor’s and Master’s of Science degrees from the University of Memphis in Engineering Technology, focused in operations management, process improvement, and industrial statistics. He also served as adjunct professor at his alma mater from 2001 to 2007.

Chris West

Chris West, President, ZeroTo510 Medical Device Accelerator
Chris West is a former executive in the pharmaceutical/biotech industry with over 20 years of experience in sales force leadership as well as tactical and strategic marketing on industry-leading brands such as Advair, Valtrex, and Avodart. He now serves as president of ZeroTo510, a nationally recognized medical device accelerator based in Memphis, Tenn. ZeroTo510 works with venture capital partners to assess and fund medical device inventors. The accelerator then leads the inventors to build the development plans necessary to gain regulatory approval for their invention, protect it with patent strategies, and maximize value with successful commercialization strategies. West moved to Memphis as vice president of sales (and company officer) for the biotech startup, GTx Inc.